Non-Surgical Aesthetic Medical Services was Aesthetic Medical International Holdings’s largest revenue line in fiscal 2025, bringing in $541.08M of $722.86M (75%).
| Products and services [axis] | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Non-Surgical Aesthetic Medical Services | $482.29M | $474.87M | $557.84M | $541.08M | |||||
| Nonsurgical Aesthetic Medical Services | — | — | — | — | |||||
| Surgical Aesthetic Medical Services | $132.63M | $143.06M | $125.37M | $126.79M | |||||
| General Healthcare Services & Other Aesthetic Medical Services | $55.18M | $64.66M | $72.47M | $54.98M | |||||
| Total | $670.09M | $682.59M | $755.67M | $722.86M |
Aesthetic Medical International Holdings brought in $722.86M from its three revenue lines in fiscal 2025, the year ended December 31, 2025. That was down 4.3% from $755.67M in fiscal 2024. Non-Surgical Aesthetic Medical Services was the largest at $541.08M (74.9%), ahead of Surgical Aesthetic Medical Services at $126.79M (17.5%) and General Healthcare Services & Other Aesthetic Medical Services at $54.98M (7.6%).
Compared with fiscal 2024, Surgical Aesthetic Medical Services grew fastest, up 1.1% to $126.79M, while General Healthcare Services & Other Aesthetic Medical Services fell the most, down 24.1% to $54.98M. From fiscal 2022 to 2025, combined revenue from these revenue lines grew from $670.09M to $722.86M, a compound annual growth rate of 2.6%. Non-Surgical Aesthetic Medical Services' share of the total rose from 72.0% to 74.9%.
Shanghai Pengai Aesthetic Medical Clinic Co., Ltd was Aesthetic Medical International Holdings’s largest revenue line in fiscal 2020, bringing in $29.84M of $131.36M (23%).
| Subsidiaries [axis] | FY 2020 |
|---|---|
| Shanghai Pengai Aesthetic Medical Clinic Co., Ltd | $29.84M |
| Shenzhen Pengai Xiuqi Aesthetic Medical Hospital Co. Ltd | $28.53M |
| Huizhou Pengai Aesthetic Medical Hospital Co., Ltd | $26.85M |
| Yantai Pengai Jiayan Cosmetic Surgery Hospital Co., Ltd | $25.96M |
| Haikou Pengai Aesthetic Medical Hospital Co., Ltd | $20.18M |
| Total | $131.36M |
Aesthetic Medical International Holdings brought in $131.36M from its five revenue lines in fiscal 2020, the year ended December 31, 2020. Shanghai Pengai Aesthetic Medical Clinic Co., Ltd was the largest at $29.84M (22.7%), ahead of Shenzhen Pengai Xiuqi Aesthetic Medical Hospital Co. Ltd at $28.53M (21.7%) and Huizhou Pengai Aesthetic Medical Hospital Co., Ltd at $26.85M (20.4%). The other two revenue lines brought in $46.14M combined.
Aesthetic Medical International Holdings (PAIYY) reports its revenue by products and services [axis] and by subsidiaries [axis]. In fiscal 2025, Non-Surgical Aesthetic Medical Services was its largest revenue line, bringing in $541.08M (74.9% of the total), followed by Surgical Aesthetic Medical Services at $126.79M (17.5%).
Non-Surgical Aesthetic Medical Services was Aesthetic Medical International Holdings' largest revenue line in fiscal 2025, bringing in $541.08M, or 74.9% of the $722.86M total across its three revenue lines.
Among Aesthetic Medical International Holdings' revenue lines that make up at least 2% of revenue, Surgical Aesthetic Medical Services grew fastest in fiscal 2025, up 1.1% from $125.37M to $126.79M.
Every figure comes from Aesthetic Medical International Holdings' annual financial filings, as reported. Each line keeps the name Aesthetic Medical International Holdings gives it, and years follow its fiscal calendar.
Aesthetic Medical International Holdings' revenue by products and services [axis] goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.